Can B Corp

Canbiola, Inc., an American corporation headquartered in Hicksville, New York, is a growing company with four employees. Operating under the stock symbol CANB on the OTCQB exchange, Canbiola focuses on the research, production, and distribution of a diverse range of cannabidiol (CBD) products. Canbiola's product portfolio encompasses oils, creams, moisturizers, chews, isolate, gel caps, and concentrates, all derived from hemp and containing no THC. The company develops its proprietary product line while actively seeking opportunities to expand its reach through strategic acquisitions in both the CBD and medical cannabis industries. Targeting a broad customer base interested in natural wellness solutions, Canbiola emphasizes the therapeutic benefits of hemp CBD for pain management, inflammation reduction, and overall well-being. Beyond its core product line, Canbiola has established a subsidiary, Pure Health Products, in Lacey, Washington, serving as the primary research and development laboratory and production facility. Additionally, the company's Duramed division has introduced a durable medical device, accessed through a network of physicians, that utilizes sustained acoustic technology (SAM) for pain and inflammation relief in patients' homes. For further information about Canbiola, its products, and its innovative initiatives, please visit their website at canbiola.com.